Study Finds Olezarsen Cuts Triglyceride Levels by About Half
Results show drug is effective and safe, leaves open question of optimal dosing
Source: dicardiology.com
Study Group At Brigham News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Study Group At Brigham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Study Group At Brigham Today - Breaking & Trending Today
AMGEN PRESENTS NEW PHASE 2 DATA THAT SHOW OLPASIRAN DELIVERS SIGNIFICANT REDUCTION IN LIPOPROTEIN(A) LEVELS
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today presented end-of-treatment data from its Phase 2 OCEAN(a)-DOSE study of investigational olpasiran (formerly AMG 890)...
Source: prnewswire.com
Full-dose anticoagulation lowers the risk of blood clotting complications in COVID-19 patients
A clinical trial of patients with COVID-19 led by investigators at the TIMI Study Group at Brigham and Women's Hospital and the Critical Care Cardiology Trials Network has found that full-dose anticoagulation lowers the risk of blood clotting complications compared with standard-dose prophylactic anticoagulation.
Source: news-medical.net
Health news: People on the move in Polk's medical community
Health news: People on the move in Polk's medical community The Ledger WINTER HAVEN HOSPITAL Winter Haven Hospital's Bostick Structural Heart Team completed its first MitraClip procedure. The MitraClip repairs a condition called mitral regurgitation. When the mitral valve fails to close completely, it can cause blood to flow backward through the heart. Left untreated, mitral regurgitation can lead to serious complications, including heart failure. This approach helps patients avoid open-heart procedures, meaning they can recover and resume their normal lives sooner. Offering such services is...
Source: theledger.com